Replies to post #2601 on Ocera Therapeutics fka OCRX

[king oil]

no CC is really lame. The management isn't doing much to promote this company's future, especially in light of the horrendous performance of its stock.

[ice1234]

STRONG BUY -revenue incised -cash balance=$20.6M looking share price over $1.47 on news from FDA any time to be relisted